IL6 and arthritic joint disease: TQ (5 mg/kg body weight) significantly downregulated the level of pro-inflammatory mediators (IL-1b, IL-6, TNF-α, and prostaglandin E2) to reduce arthritis scoring and bone leaching in collagen-induced arthritis in a Wistar rats in vivo model [35].